Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.1B | 8.3B | 8.4B | 8.3B |
Cost of revenue | 4.2B | 4.3B | 4.4B | 4.3B |
Gross profit | 4.0B | 4.0B | 4B | 4.0B |
Operating expense | ||||
Research & development | 38M | 39M | 37M | 36M |
Selling general and admin | 786M | 814M | 823M | 840M |
Other operating expenses | — | — | — | — |
Operating income | 2.2B | 2.2B | 2.2B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 60M | 284M | 68M | 70M |
Other income expense | 19M | 120M | -49M | 51M |
Pretax income | 2.2B | 2.3B | 2.1B | 2.2B |
Tax provision | 511M | 533M | 498M | 508M |
Net income | 1.7B | 1.8B | 1.6B | 1.7B |
Basic EPS | 3.5 | — | 3.2 | 3.5 |
Diluted EPS | 3.5 | — | 3.2 | 3.4 |
Basic average shares | 528.3M | — | 533.1M | 535.7M |
Diluted average shares | 531.6M | — | 536.7M | 539.3M |
EBITDA | 3.2B | 3.5B | 3.1B | 3.2B |
Net income from continuing op. | 1.7B | 1.9B | 1.6B | 1.6B |
Minority interests | -34M | -44M | -53M | -37M |
Preferred stock dividends | — | — | — | — |